RNA drug from Regeneron, Alnylam succeeds in rare autoimmune disease trial
Written by
BioPharma Dive
Published
0
comments
0
min
Cemdisiran helped control symptoms of generalized myasthenia gravis, but combination treatment with a Regeneron antibody didn't appear as effective.